Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsFixed dose combination

    Fixed Dose Combination

    Jump to

    • Pharma companies take FDC drugs off shelves after central govt ban

      Sales of Rs 807 crore will be hit due to the ban on 14 FDCs announced last week. A majority of the cocktail drugs are from the respiratory segment.

    • Won't be ethical for pharmas to bring back banned drugs: Expert

      The government had banned the FDC medicines including popular names like Corex cough syrup, Vicks and D-cold on March 10 terming them a 'risk' to humans.

    • Delhi HC strikes down ban on 344 fixed-dose combination drugs

      The Delhi High Court today quashed the government notification on March 10 that banned 344 fixed-dose combination drugs.

    • Margins recovering; expect them to normalise around 20%: GSK

      In an interview to CNBC-TV18, Andrew Aristidou, CFO of GlaxoSmithKline Pharmaceuticals spoke about the results and his outlook for the company.

    • Will maintain current EBITDA levels: Nectar Lifesciences

      In an interview with CNBC-TV18, Dinesh Dua, CEO of Nectar Lifesciences spoke about the results and his outlook for the company.

    • New products, regulatory approvals to drive growth for Glenmark

      The company is expecting strong growth in the current fiscal both from India and US. Major approvals are expected to drive growth for Glenmark, says Chairman and Managing Director Glenn Saldanha.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347